Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program

Authors :: Lore Decoster
Karin Pat
Anne Sibille
Frederic Clinckart
Sofie Joris
Stéphane Holbrechts
Marc Lambrechts
Frederique Bustin
Denis Schallier
Laurence Jacqmin
Wim Demey
Hassan Rezaei Kalantari
Veerle Surmont
Koen Deschepper
Thierry Pieters
Jean-Charles Goeminne
Medical Oncology
Clinical sciences
Laboratory of Molecular and Medical Oncology
UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - (MGD) Service d'oncologie médicale
Source :: Journal of geriatric oncology, Vol. 11, no. 5, p. 796-801 (2019)
Publication Year :: 2020
Publisher :: Elsevier Limited, 2020.
Abstract: Objectives To compare real life effectiveness and safety of nivolumab in patients with non-small cell lung cancer (NSCLC), according to age and Eastern Cooperative Group performance status (ECOG-PS). Methods We performed a retrospective analysis of patients treated with nivolumab for NSCLC within a Belgian compassionate use program from July 2015 until December 2016. Safety and effectiveness were compared between patients aged ≥70 years and

Tools